FONDAPARINUX PACKAGE INSERT PDF

The recommended dose of fondaparinux is mg once daily administered .. Instruction for self-administration is mentioned in the Package Leaflet. The needle. Mylan manufactures ARIXTRA®* (fondaparinux sodium) Injection, Solution ( Arixtra) in strengths of 25 mg05 mL 5 mgmL5 Category: Human Prescription Drug. Each pre-filled automatic safety syringe contains mg of fondaparinux .. 72 hours after the first study drug administration and continued for 90 ± 7 days, with regular .. Insert the full length of the needle perpendicularly (at an angle of.

Author: Febei Gabar
Country: Saint Kitts and Nevis
Language: English (Spanish)
Genre: Love
Published (Last): 3 June 2018
Pages: 264
PDF File Size: 15.51 Mb
ePub File Size: 7.45 Mb
ISBN: 826-4-23130-283-7
Downloads: 99100
Price: Free* [*Free Regsitration Required]
Uploader: Karisar

Some medicines and Arixtra may interfere with each other. While the use of heparin based anticoagulants have improved patient oriented outcomes in patients with thrombosis related medical conditions, they paradoxically are also known to put some patients at risk for developing the life threatening thrombosis called heparin induced thrombocytopenia HIT.

These may be signs of serious side effects. This web site is intended for Australian residents and is not a substitute for independent professional advice. Arixtra is not recommended for use during pregnancy, unless you and your doctor or pharmacist have discussed the risks and benefits involved. However, they are also known to cause clinically relevant side effects, or adverse drug events, such as bleeding including hemorrhagic stroke, gastrointestinal bleeding, osteoporosis long-term usepriapism, and hyperkalemia from inhibition of aldosterone synthesis.

Your doctor or pharmacist has weighed the risks of you using Arixtra fonddaparinux the benefits they expect it will have for you.

Arixtra should not be given as an intramuscular injection an injection into the muscle. Instructions on how to use the Arixtra syringe are contained in the package insert in each Arixtra carton.

There are number of risk factors associated with increasing the chance for a patient to develop Packagf, one of which is the type of anticoagulant ofndaparinux. Do not use Arixtra if you are breast-feeding or plan to breast-feed. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: The CMI and the CMI Search are not intended to be used by consumers to diagnose, treat, cure or prevent any disease or for any therapeutic purpose.

  24LC04B DATASHEET PDF

Arixtra helps most people at risk of blood clots following surgery, but it may have unwanted side effects in some people.

Fondaparinux (Arixtra) | – A Hematology Oncology Wiki

Information and inxert contained in this Web site are for information purposes only and pacage not intended to be used to diagnose, treat, cure or prevent any disease. You may wish to keep it to read again. The use of anticoagulants, such as unfractionated heparin UFH and low-molecular weight heparin LMWH have significantly improved patient oriented outcomes for medical conditions related to thrombotic events.

Your doctor or pharmacist has information on how to recognise and treat an overdose. For example, it is known that unfractionated heparin use, especially beyond 4 days of treatment, is known to have a greater risk for causing HIT packge compared to LMWH dalteparin, enoxaparin, and tinzaparin.

Explanation The use of anticoagulants, such as unfractionated heparin UFH and low-molecular weight heparin LMWH have significantly improved patient oriented outcomes for onsert conditions related to thrombotic events. Treatment and prevention of heparin-induced thrombocytopenia: An evaluation of the molecular weights among the heparin fondaparonux medications reveals that UFH’s molecular weight ranges from 3, to 30, daltons whereas, the LMWH range from 2, to 10, daltons.

The incidence of HIT is greatest in unfractionated heparin use fondaparinnux 4 days at therapeutic doses. Your doctor or pharmacist will discuss the possible risks and benefits of using Arixtra during breast-feeding.

Arixtra may be given for up to 31 days. If you have epidural or spinal anaesthesia a pain killing injection around the spinal cordtell your doctor or nurse immediately if you have back pain, numbness or weakness in the legs, or problems with bowel or bladder function. The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria. Consumers should be aware that the information provided by the Consumer Medicines Information CMI search CMI Search is for information purposes only and consumers should continue to obtain professional advice from a qualified healthcare professional regarding any condition for which they have searched for CMI.

  ESCLEROTERAPIA CON ESPUMA PDF

This type of blood clot, also called deep venous thrombosis, or DVT, can occur in patients who are confined to bed after hip fondapsrinux knee surgery. Tell your doctor or pharmacist if you are pregnant or intend to become pregnant. If you have not told your doctor or pharmacist about any of the above, tell them before you start using Arixtra. You may need urgent medical attention.

Fondaparinux (Arixtra)

Treatment and Prevention of Heparin Induced Thrombocytopenia: Arixtra is given to you as a subcutaneous injection an injection just under the inssert. You may need medical treatment if you get some of the side effects.

Serious side effects are rare. Linkins LA et al. All medicines can have side effects. However, the longer the use especially if used at therapeutic doses the greater the incidence of HIT. Arixtra is supplied in Australia by: While low-molecular weight heparins LMWH can also cause HIT, the incidence is much lower and appears to be related, in part, to the fondaparimux weight.

Arixtra Solution for injection –

If you pavkage about to be started on any new medicine, tell your doctor, dentist or pharmacist that you are using Arixtra. Catch up on the weekend. It is not known whether Arixtra passes into human breast milk.